Fedorak RN - Search Results

1

Within-Stool and Within-Day Sample Variability of Fecal Calprotectin in Patients With Inflammatory Bowel Disease: A Prospective Observational Study.

Du L, Foshaug R, Huang VW, Kroeker KI, Dieleman LA, Halloran BP, Wong K, Fedorak RN. Du L, et al. Among authors: fedorak rn. J Clin Gastroenterol. 2018 Mar;52(3):235-240. doi: 10.1097/MCG.0000000000000776. J Clin Gastroenterol. 2018. PMID: 28009684

2

Thiopurine methyltransferase enzyme activity determination before treatment of inflammatory bowel disease with azathioprine: effect on cost and adverse events.

Sayani FA, Prosser C, Bailey RJ, Jacobs P, Fedorak RN. Sayani FA, et al. Among authors: fedorak rn. Can J Gastroenterol. 2005 Mar;19(3):147-51. doi: 10.1155/2005/470863. Can J Gastroenterol. 2005. PMID: 15776134 Clinical Trial.

3

Effects of formal education for patients with inflammatory bowel disease: a randomized controlled trial.

Waters BM, Jensen L, Fedorak RN. Waters BM, et al. Among authors: fedorak rn. Can J Gastroenterol. 2005 Apr;19(4):235-44. doi: 10.1155/2005/250504. Can J Gastroenterol. 2005. PMID: 15861266 Clinical Trial.

4

The role of enteric microflora in inflammatory bowel disease: human and animal studies with probiotics and prebiotics.

Rioux KP, Madsen KL, Fedorak RN. Rioux KP, et al. Among authors: fedorak rn. Gastroenterol Clin North Am. 2005 Sep;34(3):465-82, ix. doi: 10.1016/j.gtc.2005.05.005. Gastroenterol Clin North Am. 2005. PMID: 16084308 Review. No abstract available.

5

Probiotics in the management of inflammatory bowel disease.

Penner RM, Fedorak RN. Penner RM, et al. Among authors: fedorak rn. MedGenMed. 2005 Jul 18;7(3):19. MedGenMed. 2005. PMID: 16369245 Free PMC article. Review. No abstract available.

6

Probiotics in the treatment of inflammatory bowel disease.

Rioux KP, Fedorak RN. Rioux KP, et al. Among authors: fedorak rn. J Clin Gastroenterol. 2006 Mar;40(3):260-3. doi: 10.1097/00004836-200603000-00019. J Clin Gastroenterol. 2006. PMID: 16633133 Review.

7

Bacterial antigens alone can influence intestinal barrier integrity, but live bacteria are required for initiation of intestinal inflammation and injury.

Sydora BC, Martin SM, Lupicki M, Dieleman LA, Doyle J, Walker JW, Fedorak RN. Sydora BC, et al. Among authors: fedorak rn. Inflamm Bowel Dis. 2006 Jun;12(6):429-36. doi: 10.1097/00054725-200606000-00001. Inflamm Bowel Dis. 2006. PMID: 16775486

8

The epidemiology of inflammatory bowel disease in Canada: a population-based study.

Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, Fedorak R, Israel D, Blanchard JF. Bernstein CN, et al. Am J Gastroenterol. 2006 Jul;101(7):1559-68. doi: 10.1111/j.1572-0241.2006.00603.x. Am J Gastroenterol. 2006. PMID: 16863561

9

The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease.

Ewaschuk JB, Tejpar QZ, Soo I, Madsen K, Fedorak RN. Ewaschuk JB, et al. Among authors: fedorak rn. Curr Gastroenterol Rep. 2006 Dec;8(6):486-98. doi: 10.1007/s11894-006-0039-z. Curr Gastroenterol Rep. 2006. PMID: 17105688 Review.

10

American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.

Clark M, Colombel JF, Feagan BC, Fedorak RN, Hanauer SB, Kamm MA, Mayer L, Regueiro C, Rutgeerts P, Sandborn WJ, Sands BE, Schreiber S, Targan S, Travis S, Vermeire S. Clark M, et al. Among authors: fedorak rn. Gastroenterology. 2007 Jul;133(1):312-39. doi: 10.1053/j.gastro.2007.05.006. Gastroenterology. 2007. PMID: 17631151

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

280 results

Search Page